WO2023136787 - PROCESS FOR THE PREPARATION OF A STERILE, HOMOGENEOUS SUSPENSION FOR INHALATION BY NEBULIZATION
National phase entry is expected:
Publication Number
WO/2023/136787
Publication Date
20.07.2023
International Application No.
PCT/TR2022/050030
International Filing Date
17.01.2022
Title **
[English]
PROCESS FOR THE PREPARATION OF A STERILE, HOMOGENEOUS SUSPENSION FOR INHALATION BY NEBULIZATION
[French]
PROCÉDÉ DE PRÉPARATION D'UNE SUSPENSION HOMOGÈNE STÉRILE POUR INHALATION PAR NÉBULISATION
Applicants **
ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
CAN, Fatih
YILMAZ, Emine
CELIK SAKIZCI, Devrim
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
Turkpatent
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2043 | |
| EPO | Filing, Examination, Granting | 8982 | |
| Japan | Filing, Examination, Granting | 2214 | |
| South Korea | Filing, Examination, Granting | 2106 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
20,085
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The invention relates to a simple, rapid, cost effective, timesaving and industrially convenient process for the preparation of a sterile, homogeneous suspension of niclosamide for inhalation by nebulization to treat SARS-CoV-2, the coronavirus that causes COVID-19. Further, the present invention also relates to a new inhalation composition comprising niclosamide, distilled water, dispersing or suspending agents, buffering agents, isotonic agents and preservatives.[French]
L'invention concerne un procédé simple, rapide, économique, représentant un gain de temps et industriellement pratique pour la préparation d'une suspension homogène stérile de niclosamide pour inhalation par nébulisation pour traiter le SARS-CoV-2, le coronavirus qui provoque la COVID-19. En outre, la présente invention concerne également une nouvelle composition d'inhalation comprenant du niclosamide, de l'eau distillée, des agents de dispersion ou de suspension, des agents tampons, des agents isotoniques et des conservateurs.